Loading…

Gastrointestinal complications following abdominal sacrocolpopexy for advanced pelvic organ prolapse

Objective The aims of this secondary analysis of the “Colpopexy And Urinary Reduction Efforts” (CARE) study were to estimate the incidence of postoperative gastrointestinal complications and identify risk factors. Study Design We prospectively identified gastrointestinal complications and serious ad...

Full description

Saved in:
Bibliographic Details
Published in:American journal of obstetrics and gynecology 2007-07, Vol.197 (1), p.78.e1-78.e7
Main Authors: Whitehead, William E., PhD, Bradley, Catherine S., MD, Brown, Morton B., PhD, Brubaker, Linda, MD, Gutman, Robert E., MD, Varner, R. Edward, MD, Visco, Anthony G., MD, Weber, Anne M., MD, Zyczynski, H., MD
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective The aims of this secondary analysis of the “Colpopexy And Urinary Reduction Efforts” (CARE) study were to estimate the incidence of postoperative gastrointestinal complications and identify risk factors. Study Design We prospectively identified gastrointestinal complications and serious adverse events (SAE) for 12 months after sacrocolpopexy. Two surgeons independently reviewed reports of ileus or small bowel obstruction (SBO). Results Eighteen percent of 322 women (average age 61.3 years) reported “nausea, emesis, bloating, or ileus” during hospitalization and 9.8% at 6 weeks. Nineteen women (5.9%; CI 3.8%, 9.1%) had a possible ileus or SBO that generated SAE reports: 4 (1.2%, CI 0.5%,3.2%) were reoperated for SBO, 11 (3.4%, CI 1.9%,6.1%) were readmitted for medical management, and 4 had a prolonged initial hospitalization. Older age ( P < .001) was a risk factor for ileus or SBO. Conclusion One in 20 women experiences significant gastrointestinal morbidity after sacrocolpopexy. This information will aid preoperative counseling.
ISSN:0002-9378
1097-6868
DOI:10.1016/j.ajog.2007.02.046